DR. RECKEWEG R76 Herbamine Forte

Product NDC: 53346-1376
11-digit product format: 533461376
Labeler code: 53346
Product ID: 53346-1376_a8bc3f20-8639-40d3-8ff1-e3ddc0a0165a
Type: HUMAN OTC DRUG
Nonproprietary name: Drosera 1X, Mentholum 2X, Convallaria majalis 3X, Lobelia inflata 3X, Stramonium 6X, Aconitum napellus 3X, Ammi visnaga 2X, Kali iodatum 3X
Dosage form: LIQUID
Route: ORAL
Labeler: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 1986-06-01
Marketing end: 0000-00-00
Substance: DROSERA ROTUNDIFOLIA; MENTHOL; CONVALLARIA MAJALIS; LOBELIA INFLATA; DATURA STRAMONIUM; ACONITUM NAPELLUS; AMMI VISNAGA FRUIT; POTASSIUM IODIDE
Active strength: 1 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53346-1376		I	Inactivated by FDA		2026-10-05
excluded package	package	53346-1376	53346-1376-5	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53346-1376-5	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53346-1376-5	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53346-1376-5	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53346-1376-5	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53346-1376-5	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53346-1376-5	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53346-1376-5	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53346-1376-5	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53346-1376-5	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53346-1376-5	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53346-1376-5	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53346-1376-5	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53346-1376-5	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53346-1376-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53346-1376-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53346-1376-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53346-1376-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53346-1376-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53346-1376-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53346-1376-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53346-1376-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53346-1376-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53346-1376-5	2020-01-31	C162847	48780-1	9d75b9d0-b4b2-f424-e053-dadaa90a57ce	DR. RECKEWEG R76 Herbamine Forte

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53346-1376-5	DR. RECKEWEG R76 Herbamine ForteCombination product	50 mL in 1 BOTTLE	LIQUID	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACONITUM NAPELLUS	ACTIVE INGREDIENT	U0NQ8555JD	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
AMMI VISNAGA FRUIT	ACTIVE INGREDIENT	3UN285QN0C	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CONVALLARIA MAJALIS	ACTIVE INGREDIENT	QHH4HVF5QE	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DATURA STRAMONIUM	ACTIVE INGREDIENT	G6W4F0V8Z3	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DROSERA ROTUNDIFOLIA	ACTIVE INGREDIENT	QR44N9XPJQ	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LOBELIA INFLATA	ACTIVE INGREDIENT	9PP1T3TC5U	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MENTHOL	ACTIVE INGREDIENT	L7T10EIP3A	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
POTASSIUM IODIDE	ACTIVE INGREDIENT	1C4QK22F9J	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ACONITUM NAPELLUS	ACTIVE MOIETY	U0NQ8555JD	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
AMMI VISNAGA FRUIT	ACTIVE MOIETY	3UN285QN0C	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CONVALLARIA MAJALIS	ACTIVE MOIETY	QHH4HVF5QE	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DATURA STRAMONIUM	ACTIVE MOIETY	G6W4F0V8Z3	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DROSERA ROTUNDIFOLIA	ACTIVE MOIETY	QR44N9XPJQ	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
IODIDE ION	ACTIVE MOIETY	09G4I6V86Q	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LOBELIA INFLATA	ACTIVE MOIETY	9PP1T3TC5U	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MENTHOL	ACTIVE MOIETY	L7T10EIP3A	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53346-1376	DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1	Legacy NDC, 1 package rows	20130514_a3d04940-cb46-44de-bdeb-7a07070ef4eb.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
QR44N9XPJQ	DROSERA ROTUNDIFOLIA		DROSERA ROTUNDIFOLIA
QHH4HVF5QE	CONVALLARIA MAJALIS		CONVALLARIA MAJALIS
9PP1T3TC5U	LOBELIA INFLATA		LOBELIA INFLATA
G6W4F0V8Z3	DATURA STRAMONIUM	8063-18-1	DATURA STRAMONIUM
U0NQ8555JD	ACONITUM NAPELLUS		ACONITUM NAPELLUS
1C4QK22F9J	POTASSIUM IODIDE	7681-11-0	POTASSIUM IODIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
53346-1376-5	53346137605	50 mL in 1 BOTTLE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DR. RECKEWEG R76 Herbamine Forte	PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO	2013-04-03	HUMAN OTC DRUG LABEL	1